« Back to Record
Citation APA

Nordlinger, B., Rougier, P., Arnaud, J.-P., Debois, M., Wils, J., Ollier, J.-C., Grobost, O., Lasser, P., Wals, J., Lacourt, J., Seitz, J.-F., dos Santos, J. G., Bleiberg, H., Mackiewickz, R., Conroy, T., Bouché, O., Morin, T., Baila, L., Van Cutsem, E., & Bedenne, L. (2005). Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: A multicentre randomised controlled phase III trial. Lancet oncology, 6(7), 459-468. doi:10.1016/S1470-2045(05)70222-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/90271

Nordlinger, B., Rougier, P., Arnaud, J.-P., Debois, M., Wils, J., Ollier, J.-C., Grobost, O., Lasser, P., Wals, J., Lacourt, J., Seitz, J.-F., dos Santos, J. G., Bleiberg, H., Mackiewickz, R., Conroy, T., Bouché, O., Morin, T., Baila, L., Van Cutsem, E., & Bedenne, L. (2005). Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: A multicentre randomised controlled phase III trial. Lancet oncology, 6(7), 459-468. doi:10.1016/S1470-2045(05)70222-9